£20.8m raised in 2024-25; 83p in every £1 spent went directly to supporting patients; commitment to invest up to £30m in research by 2030 to treble the number of patients participating in clinical trials
Key Metric 1
Around 60 patients a year now benefiting from early-phase blood cancer clinical trials funded by the Charity; TYA psychological support service has delivered 600+ sessions to 90 young patients (aged 16-24) since launching in late 2022
Key Metric 2
5,354 supporters covered 142,066km across fundraising events; over 25,000 staff from 545+ businesses chose to support the Charity; gifts in Wills support one third of the Charity's projects
Key Metric 3
Clinical trial patient Jan Ross is in complete remission from multiple myeloma following charity-funded early-phase trial; patient John McGartland in remission from gastro-oesophageal junction cancer following RNA immunotherapy trial